7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Can-Fite BioPharma Ltd
(NYSE MKT:CANF) 

CANF stock logo

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver and inflammatory disease, COVID-19 and erectile dysfunction. The company's lead drug candidate CF101 (Piclidenoson), which is in Phase III clinical tri...

Full Time Employees: 8
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Can-Fite BioPharma Days Receivable Outstanding ttm (DSO)
202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 046.1792.33138.5184.66230.83276.99323.16
Can-Fite BioPharma Op Cashflow Per Share ttm
202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 -7.15-6.13-5.11-4.09-3.06-2.04-1.020
Can-Fite BioPharma Free Cashflow Per Share ttm
202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 -7.16-6.14-5.12-4.09-3.07-2.05-1.020
Can-Fite BioPharma Cash Per Share ttm
202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 04.318.6312.9417.2521.5725.8830.19
Can-Fite BioPharma P/S ratio ttm
202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 04.388.7613.1417.5221.926.2830.66
Can-Fite BioPharma (GAAP) P/E ratio ttm
202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 -293.66-251.71-209.76-167.81-125.85-83.9-41.950
Can-Fite BioPharma P/B ratio ttm
202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 070.32140.64210.96281.28351.6421.92492.24
No extra charts and metrics for this ticker.